Monday, November 2, 2026RSS
Peptide.Wire

The daily wire on therapeutic peptides. Regulatory, research, compounding and the incretin race, condensed.

Baseline monocyte GIP receptor mRNA expression is associated with reductions in body weight and FIB-4 index after switching to tirzepatide in patients with type 2 diabetes

Diabetology international · 2027 Jan · Okuma H et

MH
By Maren Holt · Senior Reporter, GLP-1
Oct 30 20:00 ETSource: Diabetology international

From the source

Baseline monocyte GIP receptor mRNA expression is associated with reductions in body weight and FIB-4 index after switching to tirzepatide in patients with type 2 diabetes

Diabetology international · 2027 Jan · Okuma H et al.

Read at pubmed.ncbi.nlm.nih.gov
PeptiPrescribed peptides from $99/moSee all →